Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.50
21.01.21
€10.00
21.01.22
-47.52%
22.01.22

Could be very worthwhile Investment >20% year
buy
Lipocine Inc.

Start price
Target price
Perf. (%)
€32.30
21.01.21
€136.00
21.01.22
-57.58%
22.01.22

Could be very worthwhile Investment >20% year
buy
Biocept Inc.

Start price
Target price
Perf. (%)
€147.00
21.01.21
€3,000.0
21.01.22
-48.16%
22.01.22

Could be very worthwhile Investment >20% year
buy
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€30.00
04.10.21
-
04.10.22
-39.47%
10.01.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€18.94
05.01.22
-
05.01.23
-7.08%
09.01.22

Risky Investment
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€22.60
28.12.21
-
28.12.22
-32.74%
07.01.22

Probably not worthwhile Investment
Tenax Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.38
30.12.20
-
30.12.21
-41.67%
31.12.21

Probably not worthwhile Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.29
13.12.21
€20.00
13.12.22
-12.88%
30.12.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€24.60
22.12.21
-
22.12.22
-15.45%
25.12.21

Risky Investment
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€9.80
22.10.21
€1.00
22.10.22
-27.76%
16.12.21

Could be very worthwhile Investment >20% year
buy
iBio Inc.

Start price
Target price
Perf. (%)
€25.75
14.12.20
€50.00
14.12.21
-45.17%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.31
27.11.21
-
27.11.22
11.62%
12.12.21

Risky Investment
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€1.43
01.12.21
-
01.12.22
20.66%
12.12.21

Risky Investment
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.80
08.12.21
-
08.12.22
-41.43%
10.12.21

Risky Investment
buy
iBio Inc.

Start price
Target price
Perf. (%)
€17.28
02.11.21
€22.50
02.11.22
-11.72%
05.12.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.02
14.07.21
-
14.07.22
-24.07%
05.12.21

buy
Valbiotis

Start price
Target price
Perf. (%)
€7.05
26.09.21
€7.50
26.09.22
-11.49%
26.11.21

Could be worthwhile Investment >10% per year